Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2000;83:127-130; doi:10.1136/heart.83.2.127
Copyright © 2000 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2000;83:127-130 ( February )

Editorial

Homocysteine, B vitamins, and risk of cardiovascular disease

The first 150 words of the full text of this article appear below.

Homocysteine is a sulphur containing amino acid that plays an important role in methionine and folate metabolism.1 By receiving a methyl group from 5'-methyltetrahydrofolate, it is reconverted to methionine (fig 1), which is essential for many biochemical reactions critical to the formation of protein, nucleic acids, and creatinine. Reconversion of homocysteine to methionine also contributes to the maintenance of intracellular stores of tetrahydrofolate.

Figure Removed (Available Only in the Full Text)

Homocysteine has become a target for many basic and clinical investigators because of a clinical syndrome described almost 40 years ago.2 3 The syndrome, homocystinuria, is an autosomal recessive disorder characterised by abnormalities of the long bones, ocular lens dislocation, mental retardation, and aggressive vascular disease, in particular venous thromboembolism. The underlying enzymological abnormality, a deficit of cystathionine beta  synthase, results in impairment of homocysteine transsulfuration. As a consequence, the concentrations of the amino acid in plasma may rise 20-fold from the normative range of 5-15 µmol/l. About 10 years after . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Akahoshi, N., Kobayashi, C., Ishizaki, Y., Izumi, T., Himi, T., Suematsu, M., Ishii, I. (2008). Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine {beta}-synthase-deficient mice, an animal model for hyperhomocysteinemia. Hum Mol Genet 17: 1994-2005 [Abstract] [Full Text]  
  • Bozkurt, E., Keles, S., Acikel, M., Islek, M., Atesal, S. (2004). Plasma Homocysteine Level and the Angiographic Extent of Coronary Artery Disease. ANGIOLOGY 55: 265-270 [Abstract]  
  • Weiss, N., Heydrick, S., Zhang, Y.-Y., Bierl, C., Cap, A., Loscalzo, J. (2002). Cellular Redox State and Endothelial Dysfunction in Mildly Hyperhomocysteinemic Cystathionine {beta}-Synthase-Deficient Mice. Arterioscler. Thromb. Vasc. Bio. 22: 34-41 [Abstract] [Full Text]  
  • Weiss, N., Zhang, Y.-Y., Heydrick, S., Bierl, C., Loscalzo, J. (2001). Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc. Natl. Acad. Sci. USA 10.1073/pnas.231428998v1 [Abstract] [Full Text]  
  • Weiss, N., Zhang, Y.-Y., Heydrick, S., Bierl, C., Loscalzo, J. (2001). Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc. Natl. Acad. Sci. USA 98: 12503-12508 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Homocysteine, B vitamins and risk of cardiovascular disease
J Y Jeremy
Online, 25 Apr 2000 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.